share_log

Jin Medical International | 6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]

中进医疗 | 6-K:外国发行人报告

美股sec公告 ·  02/01 16:14
Moomoo AI 已提取核心信息
Jin Medical International Ltd., a foreign private issuer, has reported the appointment of Yanru Guo as an independent member of the Board and the chairperson of the audit committee, the compensation committee, and the nominating and corporate governance committee. The appointment was made by the board of directors on January 26, 2024, and took effect on January 30, 2024. Ms. Guo brings a wealth of experience to the role, having served as chief accountant at Shineco, Inc., a Nasdaq-listed company, since March 2014. Her background includes extensive knowledge of US GAAP, IFRS, and CAS, and over a decade of accounting experience in Nasdaq-listed companies. Prior to her current role, she held positions at Beijing Mobile Interactive Co. Ltd and Beijing Pacific Century Info...Show More
Jin Medical International Ltd., a foreign private issuer, has reported the appointment of Yanru Guo as an independent member of the Board and the chairperson of the audit committee, the compensation committee, and the nominating and corporate governance committee. The appointment was made by the board of directors on January 26, 2024, and took effect on January 30, 2024. Ms. Guo brings a wealth of experience to the role, having served as chief accountant at Shineco, Inc., a Nasdaq-listed company, since March 2014. Her background includes extensive knowledge of US GAAP, IFRS, and CAS, and over a decade of accounting experience in Nasdaq-listed companies. Prior to her current role, she held positions at Beijing Mobile Interactive Co. Ltd and Beijing Pacific Century Info-Tech Co., Ltd. Ms. Guo has earned a master's degree in accounting and a bachelor's degree in management and accounting, and holds a CPA Certificate in China. Her appointment satisfies the 'independence' requirements of the Nasdaq listing rule and Rule 10A-3 under the Securities Exchange Act. The formal announcement of her appointment was signed by Erqi Wang on behalf of Jin Medical International Ltd. on February 1, 2024.
外国私人发行人金医疗国际有限公司报告说,郭艳如被任命为董事会独立成员以及审计委员会、薪酬委员会及提名和公司治理委员会主席。该任命由董事会于 2024 年 1 月 26 日作出,并于 2024 年 1 月 30 日生效。郭女士自2014年3月起在纳斯达克上市公司Shineco, Inc. 担任首席会计师,为该职位带来了丰富的经验。她的背景包括对美国公认会计原则、国际财务报告准则和CAS的广泛了解,以及在纳斯达克上市公司拥有十多年的会计经验。在担任现任职务之前,她曾在北京移动互动有限公司任职。Ltd. 和北京盈科信息技术有限公司。郭女士拥有会计学硕士学位和管理与会计学士学位,并持有中国注册会计师证书。她的任命符合纳斯达克上市规则和《证券交易法》第10A-3条的 “独立性” 要求。她的正式任命公告由王尔奇代表金医疗国际有限公司于2024年2月1日签署。
外国私人发行人金医疗国际有限公司报告说,郭艳如被任命为董事会独立成员以及审计委员会、薪酬委员会及提名和公司治理委员会主席。该任命由董事会于 2024 年 1 月 26 日作出,并于 2024 年 1 月 30 日生效。郭女士自2014年3月起在纳斯达克上市公司Shineco, Inc. 担任首席会计师,为该职位带来了丰富的经验。她的背景包括对美国公认会计原则、国际财务报告准则和CAS的广泛了解,以及在纳斯达克上市公司拥有十多年的会计经验。在担任现任职务之前,她曾在北京移动互动有限公司任职。Ltd. 和北京盈科信息技术有限公司。郭女士拥有会计学硕士学位和管理与会计学士学位,并持有中国注册会计师证书。她的任命符合纳斯达克上市规则和《证券交易法》第10A-3条的 “独立性” 要求。她的正式任命公告由王尔奇代表金医疗国际有限公司于2024年2月1日签署。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息